Cargando…
A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids
We describe for the first time a method that utilizes microscale thermophoresis (MST) technology to determine polyclonal antibody affinities to small molecules. Using a novel type of heterologous MST, we have accurately measured a solution-based binding affinity of serum antibodies to heroin which w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956019/ https://www.ncbi.nlm.nih.gov/pubmed/29675707 http://dx.doi.org/10.1007/s00216-018-1060-4 |
_version_ | 1783323811344547840 |
---|---|
author | Torres, Oscar B. Duval, Alexander J. Sulima, Agnieszka Antoline, Joshua F. G. Jacobson, Arthur E. Rice, Kenner C. Alving, Carl R. Matyas, Gary R. |
author_facet | Torres, Oscar B. Duval, Alexander J. Sulima, Agnieszka Antoline, Joshua F. G. Jacobson, Arthur E. Rice, Kenner C. Alving, Carl R. Matyas, Gary R. |
author_sort | Torres, Oscar B. |
collection | PubMed |
description | We describe for the first time a method that utilizes microscale thermophoresis (MST) technology to determine polyclonal antibody affinities to small molecules. Using a novel type of heterologous MST, we have accurately measured a solution-based binding affinity of serum antibodies to heroin which was previously impossible with other currently available methods. Moreover, this mismatch approach (i.e., using a cross-reactive hapten tracer) has never been reported in the literature. When compared with equilibrium dialysis combined with ultra-performance liquid chromatography/tandem mass spectrometry (ED-UPLC/MS/MS), this novel MST method yields similar binding affinity values for polyclonal antibodies to the major heroin metabolites 6-AM and morphine. Additionally, we herein report the method of synthesis of this novel cross-reactive hapten, MorHap-acetamide—a useful analog for the study of heroin hapten–antibody interactions. Using heterologous MST, we were able to determine the affinities, down to nanomolar accuracies, of polyclonal antibodies to various abused opioids. While optimizing this method, we further discovered that heroin is protected from serum esterase degradation by the presence of these antibodies in a concentration-dependent manner. Lastly, using affinity data for a number of structurally different opioids, we were able to dissect the moieties that are crucial to antibody binding. The novel MST method that is presented herein can be extended to the analysis of any ligand that is prone to degradation and can be applied not only to the development of vaccines to substances of abuse but also to the analysis of small molecule/protein interactions in the presence of serum. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00216-018-1060-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5956019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-59560192018-05-18 A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids Torres, Oscar B. Duval, Alexander J. Sulima, Agnieszka Antoline, Joshua F. G. Jacobson, Arthur E. Rice, Kenner C. Alving, Carl R. Matyas, Gary R. Anal Bioanal Chem Research Paper We describe for the first time a method that utilizes microscale thermophoresis (MST) technology to determine polyclonal antibody affinities to small molecules. Using a novel type of heterologous MST, we have accurately measured a solution-based binding affinity of serum antibodies to heroin which was previously impossible with other currently available methods. Moreover, this mismatch approach (i.e., using a cross-reactive hapten tracer) has never been reported in the literature. When compared with equilibrium dialysis combined with ultra-performance liquid chromatography/tandem mass spectrometry (ED-UPLC/MS/MS), this novel MST method yields similar binding affinity values for polyclonal antibodies to the major heroin metabolites 6-AM and morphine. Additionally, we herein report the method of synthesis of this novel cross-reactive hapten, MorHap-acetamide—a useful analog for the study of heroin hapten–antibody interactions. Using heterologous MST, we were able to determine the affinities, down to nanomolar accuracies, of polyclonal antibodies to various abused opioids. While optimizing this method, we further discovered that heroin is protected from serum esterase degradation by the presence of these antibodies in a concentration-dependent manner. Lastly, using affinity data for a number of structurally different opioids, we were able to dissect the moieties that are crucial to antibody binding. The novel MST method that is presented herein can be extended to the analysis of any ligand that is prone to degradation and can be applied not only to the development of vaccines to substances of abuse but also to the analysis of small molecule/protein interactions in the presence of serum. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00216-018-1060-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-04-19 2018 /pmc/articles/PMC5956019/ /pubmed/29675707 http://dx.doi.org/10.1007/s00216-018-1060-4 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Paper Torres, Oscar B. Duval, Alexander J. Sulima, Agnieszka Antoline, Joshua F. G. Jacobson, Arthur E. Rice, Kenner C. Alving, Carl R. Matyas, Gary R. A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids |
title | A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids |
title_full | A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids |
title_fullStr | A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids |
title_full_unstemmed | A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids |
title_short | A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids |
title_sort | rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956019/ https://www.ncbi.nlm.nih.gov/pubmed/29675707 http://dx.doi.org/10.1007/s00216-018-1060-4 |
work_keys_str_mv | AT torresoscarb arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT duvalalexanderj arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT sulimaagnieszka arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT antolinejoshuafg arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT jacobsonarthure arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT ricekennerc arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT alvingcarlr arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT matyasgaryr arapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT torresoscarb rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT duvalalexanderj rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT sulimaagnieszka rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT antolinejoshuafg rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT jacobsonarthure rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT ricekennerc rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT alvingcarlr rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids AT matyasgaryr rapidsolutionbasedmethodfordeterminingtheaffinityofheroinhapteninducedantibodiestoheroinitsmetabolitesandotheropioids |